Libertyville, IL, United States of America

Edward B Reilly

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 86(Granted Patents)


Location History:

  • Libertyville, CA (US) (2019)
  • Libertyville, IL (US) (2008 - 2020)

Company Filing History:


Years Active: 2008-2020

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Spotlight on Inventor Edward B. Reilly

Introduction:

Edward B. Reilly, a prominent inventor based in Libertyville, IL, has made significant contributions to the field of biotechnology with a total of 10 patents to his name. His innovative work has had a profound impact on the healthcare industry, particularly in the treatment of cancer.

Latest Patents:

Among his recent patents is the groundbreaking invention of Anti-cMet antibody drug conjugates. These conjugates have shown promising results in binding with human cMET, offering new avenues for treating cancer patients. The methods of making and utilizing these conjugates mark a significant advancement in targeted cancer therapies.

Career Highlights:

Edward B. Reilly has been associated with renowned companies such as AbbVie Inc. and AbbVie Biotherapeutics Inc. His tenure at these organizations has provided him with invaluable experience and resources to further his research and development endeavors. His extensive knowledge and expertise in the field have led to the successful creation of patented technologies that have the potential to revolutionize the healthcare landscape.

Collaborations:

Throughout his career, Edward B. Reilly has collaborated with esteemed professionals in the industry, including Chung-Ming Hsieh and Andrew C. Phillips. These collaborations have not only enriched his own work but have also contributed to the collective advancement of biotechnological innovations. The exchange of ideas and expertise among these experts has fostered a culture of creativity and progress within the field.

Conclusion:

In conclusion, Edward B. Reilly's innovative spirit and dedication to scientific inquiry have positioned him as a key figure in the realm of biotechnological inventions. His latest patents, particularly in the development of Anti-cMet antibody drug conjugates, underscore his commitment to advancing cancer treatment modalities. With a proven track record of success and a strong collaborative network, Edward B. Reilly continues to pave the way for cutting-edge innovations that hold the potential to benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…